title: Scheduling-dependent interaction for the combination of cytosine arabinoside and daunorubicin on HL-60 cells.
authors.forename: P A
authors.initials: PA
authors.lastname: Bernabei
authors.forename: G
authors.initials: G
authors.lastname: Rombolà
authors.forename: R
authors.initials: R
authors.lastname: Saccardi
authors.forename: R
authors.initials: R
authors.lastname: Bezzini
authors.forename: V
authors.initials: V
authors.lastname: Santini
authors.forename: C
authors.initials: C
authors.lastname: Pifferi
authors.forename: V
authors.initials: V
authors.lastname: Gattei
authors.forename: P R
authors.initials: PR
authors.lastname: Ferrini
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D004347:Drug Interactions; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D014407:Tumor Cells, Cultured / Q000187:drug effects
chemical_list: D003561:Cytarabine; D003630:Daunorubicin